LMRT Alumni Andrew Warren Named as Part of Forbes 30 under 30

November 14, 2017

Forbes' list of "30 under 30" is presented to a selected group of young entrepreneurs, innovators and game changers. Andrew Warren, Founding Scientist and Product Development Lead at Glympse Bio, was selected in Forbes' list of 30 under 30 for 2018 in Healthcare. Glympse Bio uses modular nanoparticle sensors to create diagnostics for diseases potentially including cancer, clotting disorders and liver fibrosis. 


You can read more about the award here.